ProCE Banner Activity

Risk Scores for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B

Clinical Thought
HCC risk scores can inform a personalized approach to HCC surveillance in patients with chronic hepatitis B by allowing patients at very low risk to avoid burdensome surveillance and identifying high-risk patients who may benefit from intensive surveillance

Released: June 04, 2021

Expiration: June 03, 2022

No longer available for credit.

Share

Faculty

Norah Terrault

Norah Terrault, MD, MPH

Assistant Professor, Medicine and Surgery
Director of Viral Hepatitis Research, Liver Transplantation Program
University of California, San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Norah Terrault, MD, MPH

Assistant Professor, Medicine and Surgery
Director of Viral Hepatitis Research, Liver Transplantation Program
University of California, San Francisco
San Francisco, California

Norah Terrault, MD, MPH, has disclosed that she has received funds for research support from Gilead Sciences, GlaxoSmithKline, and Roche/Genentech.